➤ Preservative-free fixed-dose combination therapy for glaucoma in development ➤ Rare Pediatric Disease designation granted to investigational Stargardt gene therapy ➤ First patient dosed in genome editing program for corneal dystrophy ➤ ASCRS news and events
➤ Positive update from Phase 2 study evaluating oligonucleotide for AMD and DME ➤ 18-month data presented on novel drug delivery platform ➤ Phase 1/2a trial results for intravitreal injection for treatment of glaucoma ➤ Advancing AI to facilitate detection and improve management of ocular disease ➤ Fast Track designation granted for neuropathic corneal pain ➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy ➤ ASCRS news and events
➤ ASCRS EyeWorld Weekly: View the current issue ➤ Study: COVID-19 significantly reduced rate of ophthalmic procedures ➤ New device provides non-surgical treatment for lower lid laxity ➤ Autonomous Diabetic Retinopathy Screening offers ‘unparalleled results’ ➤ 52-week data from Phase 2b study evaluating wet AMD therapy ➤ Subgroup analysis provides additional data on wet AMD therapy ➤ ASCRS news and events